The MD Magazine Opioid-induced Constipation condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
The number of opioid-related deaths nearly quadrupled from 1999 to 2011 in the US; and while that number continues to increase, one state has made positive strides with the implementation of two initiatives.
Researchers who looked at the potential association between post-diagnosis opioid use and breast cancer recurrence found no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.
A recent study looked at the safety and efficacy of prolonged-release forms of two common opioids—oxycodone and naloxone—in treating chronic pain and opioid-induced constipation, which affects in as many as 40% of opioid-treated patients.
For patients unable to have regular bowel movements the search for effective treatment can be uncomfortable with limited options. A potential new treatment is being tested where a vibrating capsule could help these patients with regular bodily functions.
With 259 million painkiller prescriptions written in 2012 alone, according to the Centers for Disease Control and Prevention (CDC), one of the most common side effects experienced by patients being treated for chronic pain is opioid-induced constipation (OIC).
Studies show that nutrient-dense yogurt may benefit individuals with lactose intolerance, constipation and diarrheal diseases, hypertension, cardiovascular diseases, diabetes, and certain types of cancer.
The opioid epidemic began nearly 30 years ago and since that time small steps have been taken to reverse its effects. The question remains whether too much damage has already been done to fix the problems in a timely manner.